Diabetic foot disease is a source of major patient suffering and societal costs. Investing in evidence-based international guidelines on diabetic foot disease is likely among the most cost-effective forms of health care expenditure, provided the guidelines are outcome focused, evidence based, and properly implemented. The International Working Group on the Diabetic Foot (IWGDF) has published and updated international guidelines since 1999. The 2019 updates are based on formulating relevant clinical questions and outcomes, rigorous systematic reviews of the literature, and recommendations that are specific, and unambiguous along with their transparent rationale, all using the Grading of Recommendations Assessment Development and Evaluation (...
Diabetes-related foot disease results in a major global burden for patients and the healthcare syste...
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines...
Aims This is the 2023 International Working Group on the Diabetic Foot guideline on the prevention ...
Diabetic foot disease is a source of major patient suffering and societal costs. Investing in eviden...
Aims: Diabetes-related foot disease is a major source of patient burden and societal costs. Investin...
Diabetic foot disease results in a major global burden for patients and the health care system. The ...
Diabetic foot ulcers are the source of major suffering and very large costs for both the patient and...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
The future for diabetes is grave. Now described as the global epidemic of the 21st century, the incr...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Diabetes-related foot disease results in a major global burden for patients and the healthcare syste...
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines...
Aims This is the 2023 International Working Group on the Diabetic Foot guideline on the prevention ...
Diabetic foot disease is a source of major patient suffering and societal costs. Investing in eviden...
Aims: Diabetes-related foot disease is a major source of patient burden and societal costs. Investin...
Diabetic foot disease results in a major global burden for patients and the health care system. The ...
Diabetic foot ulcers are the source of major suffering and very large costs for both the patient and...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
The future for diabetes is grave. Now described as the global epidemic of the 21st century, the incr...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Diabetes-related foot disease results in a major global burden for patients and the healthcare syste...
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines...
Aims This is the 2023 International Working Group on the Diabetic Foot guideline on the prevention ...